Novartis gene therapy for leukemia wins U.S. approval
August 30, 2017 at 11:06 AM EDT
Aug 30 (Reuters) - The U.S. Food and Drug Administration (FDA) on Wednesday approved Novartis AG's keenly anticipated leukemia treatment, marking the first gene therapy approval in the United States.
